Department of Radiation Oncology and OncoRay, National Center for Radiation Research in Oncology, Dresden, Germany.
Strahlenther Onkol. 2011 May;187(5):306-10. doi: 10.1007/s00066-011-2210-1. Epub 2011 Apr 26.
Previous experiments showed that the fraction of radiobiologically hypoxic tumor cells (rHF) in un-treated tumors did not accurately predict local tumor control after fractionated irradiation. Thus, the prognostic value of rHF determined during fractionated irradiation was investigated.
Six human squamous cell carcinoma lines were transplanted into nude mice and then irradiated with 15 fractions over 3 weeks. Thereafter, single dose irradiation under normal and clamped blood flow was given. Local tumor control rates were used to calculate the rHF and the TCD₅₀, i.e., the radiation dose necessary to control 50% of the tumors, after single dose irradiation. These values were compared with the in parallel determined TCD₅₀ after 30 fractions in 6 weeks.
The rHF after 15 fractions varied between 28% and 100%. No correlation was found with the TCD₅₀ after 30 fractions in 6 weeks. Single dose top-up TCD₅₀ under ambient and clamp conditions after 15 fractions significantly correlated with TCD₅₀ after 30 fractions in 6 weeks.
rHF after 15 fractions is not a prognostic parameter for the outcome after fractionated irradiation. In contrast, the radiobiological parameters number of tumor stem cells, intrinsic radiosensitivity, and number of radiobiologically hypoxic tumor cells appear promising to predict outcome after fractionated irradiation.
先前的实验表明,未经治疗的肿瘤中放射生物学低氧肿瘤细胞(rHF)的比例并不能准确预测分割照射后的局部肿瘤控制。因此,研究了在分割照射过程中确定的 rHF 的预后价值。
将 6 个人鳞状细胞癌系移植到裸鼠中,然后用 15 个分数在 3 周内进行照射。此后,在正常和夹闭血流条件下进行单次剂量照射。使用局部肿瘤控制率来计算 rHF 和 TCD₅₀,即在单次剂量照射下控制 50%肿瘤所需的辐射剂量。将这些值与在 6 周内用 30 个分数平行确定的 TCD₅₀进行比较。
15 个分数后的 rHF 介于 28%至 100%之间。与 6 周内 30 个分数的 TCD₅₀ 之间没有相关性。在 15 个分数后,在环境和夹闭条件下进行单次剂量补充 TCD₅₀ 与 6 周内 30 个分数的 TCD₅₀ 显著相关。
15 个分数后的 rHF 不是分割照射后结果的预后参数。相比之下,肿瘤干细胞数量、内在放射敏感性和放射生物学低氧肿瘤细胞数量等放射生物学参数似乎有望预测分割照射后的结果。